Ingo Mellinghoff
Chair, Department of Neurology · New York Presbyterian Hospital
Credentials: · · · ·
History
PresentDepartment of Neurology · New York Presbyterian Hospital
- Present
Neurology Department · New York Presbyterian Hospital
1996–1998- 1989–1993
Research
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Nature Genetics · 2019 · 3,156 citations
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Nature · 2012 · 1,631 citations
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Nature · 2012 · 1,578 citations
42 papers
- PW
32 papers
- LD
26 papers
- TK
25 papers
22 papers
- RY
22 papers
21 papers
21 papers
Grants
- 2018–2025
Molecular Mechanisms of Drug Resistance in Primary Brain Tumors
National Institute of Neurological Disorders and Stroke · R35
Contact PI · $4.7M · Sloan-Kettering Inst Can Research
- 2012–2018
Molecular Mechanisms of IDH1-Mediated Gliomagenesis
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $2M · Sloan-Kettering Inst Can Research
Clinical trials
- 2019–2030
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Site PI · Recruiting · Phase 2, Phase 3
Global Coalition for Adaptive Research